Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Genome Editing Market

4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Genome Editing Market Analysis and Forecasts, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
    5.1. Regulatory Scenario
    5.2. Technological Advancements
    5.3. Covid-19 Pandemic Impact on Industry

6. Global Genome Editing Market Analysis and Forecasts, By Technology
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Technology, 2017-2031
        6.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        6.3.2. Transcription activator-like effector nuclease (TALEN)
        6.3.3. Zinc finger nuclease (ZFN)
        6.3.4. Other technologies
    6.4. Market Attractiveness By Technology

7. Global Genome Editing Market Analysis and Forecasts, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Application, 2017-2031
        7.3.1. Cell Line Editing
        7.3.2. Animal Genome Editing
        7.3.3. Plant Genome Editing
        7.3.4. Others
    7.4. Market Attractiveness By Application

8. Global Genome Editing Market Analysis and Forecasts, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By End-user, 2017-2031
        8.3.1. Pharmaceutical Companies and Biotechnology Companies
        8.3.2. Academics and Government Research Institutes
        8.3.3. Clinical Research Organizations
    8.4. Market Attractiveness By End-user

9. Global Genome Editing Market Analysis and Forecasts, By Region
    9.1. Key Findings
    9.2. Market Value Forecast By Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness By Country/Region

10. North America Genome Editing Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Technology, 2017-2031
        10.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        10.2.2. Transcription activator-like effector nuclease (TALEN)
        10.2.3. Zinc finger nuclease (ZFN)
        10.2.4. Other technologies
    10.3. Market Value Forecast By Application, 2017-2031
        10.3.1. Cell Line Editing
        10.3.2. Animal Genome Editing
        10.3.3. Plant Genome Editing
        10.3.4. Others
    10.4. Market Value Forecast By End-user, 2017-2031
        10.4.1. Pharmaceutical Companies and Biotechnology Companies
        10.4.2. Academics and Government Research Institutes
        10.4.3. Clinical Research Organizations
    10.5. Market Value Forecast By Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Technology
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country

11. Europe Genome Editing Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Technology, 2017-2031
        11.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        11.2.2. Transcription activator-like effector nuclease (TALEN)
        11.2.3. Zinc finger nuclease (ZFN)
        11.2.4. Other technologies
    11.3. Market Value Forecast By Application, 2017-2031
        11.3.1. Cell Line Editing
        11.3.2. Animal Genome Editing
        11.3.3. Plant Genome Editing
        11.3.4. Others
    11.4. Market Value Forecast By End-user, 2017-2031
        11.4.1. Pharmaceutical Companies and Biotechnology Companies
        11.4.2. Academics and Government Research Institutes
        11.4.3. Clinical Research Organizations
    11.5. Market Value Forecast By Country, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Technology
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country

12. Asia Pacific Genome Editing Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Technology, 2017-2031
        12.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        12.2.2. Transcription activator-like effector nuclease (TALEN)
        12.2.3. Zinc finger nuclease (ZFN)
        12.2.4. Other technologies
    12.3. Market Value Forecast By Application, 2017-2031
        12.3.1. Cell Line Editing
        12.3.2. Animal Genome Editing
        12.3.3. Plant Genome Editing
        12.3.4. Others
    12.4. Market Value Forecast By End-user, 2017-2031
        12.4.1. Pharmaceutical Companies and Biotechnology Companies
        12.4.2. Academics and Government Research Institutes
        12.4.3. Clinical Research Organizations
    12.5. Market Value Forecast By Country, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Technology
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country
13. Latin America Genome Editing Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Technology, 2017-2031
        13.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        13.2.2. Transcription activator-like effector nuclease (TALEN)
        13.2.3. Zinc finger nuclease (ZFN)
        13.2.4. Other technologies
    13.3. Market Value Forecast By Application, 2017-2031
        13.3.1. Cell Line Editing
        13.3.2. Animal Genome Editing
        13.3.3. Plant Genome Editing
        13.3.4. Others
    13.4. Market Value Forecast By End-user, 2017-2031
        13.4.1. Pharmaceutical Companies and Biotechnology Companies
        13.4.2. Academics and Government Research Institutes
        13.4.3. Clinical Research Organizations
    13.5. Market Value Forecast By Country, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Technology
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country
14. Middle East & Africa Genome Editing Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Technology, 2017-2031
        14.2.1. Clustered regularly interspaced short palindromic repeats (CRISPR)
        14.2.2. Transcription activator-like effector nuclease (TALEN)
        14.2.3. Zinc finger nuclease (ZFN)
        14.2.4. Other technologies
    14.3. Market Value Forecast By Application, 2017-2031
        14.3.1. Cell Line Editing
        14.3.2. Animal Genome Editing
        14.3.3. Plant Genome Editing
        14.3.4. Others
    14.4. Market Value Forecast By End-user, 2017-2031
        14.4.1. Pharmaceutical Companies and Biotechnology Companies
        14.4.2. Academics and Government Research Institutes
        14.4.3. Clinical Research Organizations
    14.5. Market Value Forecast By Country, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Technology
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of companies)
    15.2. Market Share Analysis By Company (2022)
    15.3. Company Profiles
        15.3.1. Merck KGaA
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. AstraZeneca
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Takara Bio Inc.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Cellectis SA
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. CRISPR Therapeutics
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Cibus Inc.
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. RECOMBINETICS
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Sangamo Therapeutics
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Thermo Fisher Scientific, Inc.
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Genome Editing Market Size, by Technology, 2022

Figure 02: Global Genome Editing Market Share (%), by Technology, 2022

Figure 03: Global Genome Editing Market Size, by Application, 2022

Figure 04: Global Genome Editing Market Share (%), by Application, 2022

Figure 05: Global Genome Editing Market Size, by End-user, 2022

Figure 06: Global Genome Editing Market Share (%), by End-user, 2022

Figure 07: Global Genome Editing Market, by Region (2022-2031)

Figure 08: Global Genome Editing Market Value (US$ Mn) Forecast, 2017-2031

Figure 09: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 10: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022

Figure 11: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2031

Figure 12: Global Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 13: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 14: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022

Figure 15: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2031

Figure 16: Global Genome Editing Market Attractiveness Analysis, by Application, 2023-2031

Figure 17: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 18: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 19: Global Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2031

Figure 20: Global Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

Figure 21: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2022-2031

Figure 22: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2022

Figure 23: Global Genome Editing Market Value (US$ Mn) Share Analysis, by Region, 2031

Figure 24: Global Genome Editing Market Attractiveness Analysis, by Region, 2023-2031

Figure 25: North America Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 26: North America Genome Editing Market Value Share Analysis, by Country, 2022-2031

Figure 27: North America Genome Editing Market Attractiveness Analysis, by Country, 2023-2031

Figure 28: North America Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 29: North America Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 30: North America Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 31: North America Genome Editing Market Attractiveness Analysis, by Application, 2023-31

Figure 32: North America Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 33: North America Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

Figure 34: Europe Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 35: Europe Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 36: Europe Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 37: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 38: Europe Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 39: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 40: Europe Genome Editing Market Attractiveness Analysis, by Application, 2023-2031

Figure 41: Europe Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 42: Europe Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

Figure 43: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 44: Asia Pacific Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 45: Asia Pacific Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 46: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 47: Asia Pacific Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 48: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 49: Asia Pacific Genome Editing Market Attractiveness Analysis, by Application, 2023-2031

Figure 50: Asia Pacific Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 51: Asia Pacific Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

Figure 52: Latin America Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 53: Latin America Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 54: Latin America Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 55: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 56: Latin America Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 57: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 58: Latin America Genome Editing Market Attractiveness Analysis, by Application, 2023-2031

Figure 59: Latin America Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 60: Latin America Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

Figure 61: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 62: Middle East & Africa Genome Editing Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 63: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 64: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by Technology, 2022-2031

Figure 65: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Technology, 2023-2031

Figure 66: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by Application, 2022-2031

Figure 67: Middle East & Africa Genome Editing Market Attractiveness Analysis, by Application, 2023-2031

Figure 68: Middle East & Africa Genome Editing Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031

Figure 69: Middle East & Africa Genome Editing Market Attractiveness Analysis, by End-user, 2023-2031

List of Tables

List of Tables

Table 01: Global Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 02: Global Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 03: Global Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 04: Global Genome Editing Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 05: North America Genome Editing Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 06: North America Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 07: North America Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 08: North America Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 09: Europe Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 10: Europe Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 11: Europe Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 12: Europe Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 13: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 15: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 16: Asia Pacific Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 17: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 19: Latin America Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 20: Latin America Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 23: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Middle East & Africa Genome Editing Market Value (US$ Mn) Forecast, by End-user, 2017-2031